InsidersTradesSigma
Follow the 博拓生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 博拓生物 has published 4 reports. Market capitalisation: €5.2bn. The latest transaction was filed on 8 May 2025 (Sale). Among the most active insiders: 高红梅. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€249,397
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,417 of 28,752 companies
51.9
score / 100
Value37
Quality67
FCF yld-0.5%
Earn yld1.0%
EV/EBITDA·
ROE1.2%
Gross mgn46%
Net mgn11%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 May 2025
About 博拓生物
博拓生物 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative biopharmaceutical solutions.